Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RI-001 in Immunosuppressed RSV Infected Patients
NCT00632463Phase 2Completed
- Sponsor
- ADMA Biologics, Inc.
- Start
- Feb 2008
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of RI-001 in respiratory syncytial virus infection (RSV), sponsored by ADMA Biologics, Inc.. Started Feb 2008; status: completed.
02
Drugs
RI-001
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT00632463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632463.